Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi

Borrelia burgdorferi is the causative agent of Lyme borreliosis. Antibiotic therapy of early acute infection is effective for most patients, but 10 to 20% go on to develop posttreatment Lyme disease syndrome (PTLDS). The nature of PTLDS remains unknown, but currently approved antibiotics for the tre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Wu, Xiaoqian, Sharma, Bijaya, Niles, Samantha, O'Connor, Kathleen, Schilling, Rebecca, Matluck, Nicole, D'Onofrio, Anthony, Hu, Linden T., Lewis, Kim
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2018
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201113/
https://ncbi.nlm.nih.gov/pubmed/30126963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01201-18
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires